Your HFE genotype suggests you maintain higher circulating iron levels than most people.

In the 5 months leading up to your marathon, iron saturation fell from 41% to 32% while your Resilience Score remained below your baseline as you trained 5 days per week. Six months after your race, your iron saturation rebounded by 29% and your Resilience improved by 16% after returning to 2 endurance sessions per week. This pattern suggests the demands of marathon training may have exceeded your body's ability to replenish the iron required to recover fully.

Your HFE genotype suggests you absorb iron more efficiently.

Over the last 6 months, you tripled your intake of iron-rich foods by increasing red meat consumption to 3x a week and adding a daily organ supplement to your routine. During that same period, your ferritin increased 86%, your endurance score improved 18%, and your post-exercise heart rate recovered 27 seconds faster. Few people see that large of a biological response from a dietary change alone, suggesting iron availability may be playing a larger role in your performance than it does for the average person.

Your HFE genotype influences how efficiently your body manages iron during periods of growth and repair.

Over the last 16 months, you gained 13 lbs of lean mass while reducing body fat by 7%. During that same period, Total Iron-Binding Capacity declined 19% and your Resilience Score improved 24%. This combination suggests your body became more efficient at managing iron levels during recovery, allowing a greater share of resources to support muscle growth and adaptation.

Your TMPRSS6 variant can make declines in hemoglobin more likely to affect recovery and training adaptation than they do for most people.

Over the last 18 months, hemoglobin declined by 7% while your average Strain increased by over 31%. During that same period, your Resilience Score improved by just 2%. This pattern suggests your body was spending more energy keeping up with training than adapting to it. As hemoglobin declined, oxygen delivery likely became a bottleneck, limiting the resilience gains typically seen with a 31% increase in training load.

Your TMPRSS6 variant can make it harder for you to build the oxygen-carrying red blood cells needed to support prolonged performance.

Since reducing your endurance training from 5 sessions per week to 2, your mean corpuscular volume (MCV) increased 6% over the following 6 months. During that same period, your 1,000-meter row time improved by 14 seconds which suggests decreasing weekly endurance session  improved both your red blood cell health and helped you row faster  for longer.

Your TMPRSS6 variant can make your ability to recover more sensitive to changes in red blood cell health than for most people.

In the last 4-months you averaged less than 6.5 hours of sleep per night 5 or more nights a week and your MCH declined by 7%. During that same period, your Baseline Score fell by 11 points despite maintaining a similar training load. Inadequate recovery due to lack of sleep may have reduced your body's ability to produce the oxygen-carrying red blood cells required to support your testing performance.

Your ACTN3 variant is associated with greater fast-twitch muscle fiber function and a stronger response to explosive training.

During Q2, when you completed 3 strength-training sessions per week and averaged 650 calories burned per workout, your Creatine Kinase (CK), a marker of muscle stress and repair, increased by 22%. During that same period, your Power Score increased 47 average watts from your last score. The increased muscular demand coincided with one of your largest improvements in power, suggesting your body may adapt particularly well to higher-intensity training.

Your ACTN3 genotype gives you a higher ceiling for power production, but only when you prioritize recovery.

Looking across the last 12 months, the largest declines in your Power Score was during periods where you traveled 3 or more times per month. During those months your deep sleep was 22% lower on average, and your testosterone sat 18% lower than your annual baseline. The power advantages associated with your ACTN3 genotype were hardest for you to maintain during periods of frequent travel and reduced recovery.

Your ACTN3 genotype is associated with a stronger response to strength training, but that advantage depends on having enough energy available to recover and adapt.

Over the last 4-months you trained on average 5 times per week while maintaining a significant calorie deficit. During this time, IGF-1, a hormone involved in muscle growth and recovery, declined 19%, as did your Baseline score by 7 points. Your caloric restriction decreased your body's ability to recover and adapt to training, resulting in lower athletic performance despite maintaining a similar workload.

Your PNPLA3 genotype can make your liver health more sensitive to changes in body composition than the average person.

During Q1, you lost 18 lbs by maintaining a calorie deficit and averaged 8,500 steps per day. During this same period, your ALT, a marker of liver stress and fat accumulation, decreased from 53 U/L to 35 U/L, and your fasting insulin decreased from 12.4 to 9.6 μIU/mL. Reducing your excess body fat decreased the amount of fat being stored in your liver and improved insulin sensitivity which created a healthier metabolic environment for long-term weight management.

Your PNPLA3 genotype can make your liver more sensitive to periods of weight gain and excess alcohol consumption than for most people.

During Q1,  your body weight increased from 182 lbs to 191 lbs and your alcohol intake averaged 9 drinks per week. During this same period, your AST, a marker of stress within your liver and muscle tissue, increased from 27 U/L to 43 U/L, and your fasting insulin increased from 8.1 to 11.4 μIU/mL. The combination of weight gain and increased alcohol consumption placed additional stress on your liver, reducing its ability to efficiently manage calories, blood sugar, and fat storage. If this pattern continues your PNPLA3 genotype can make future weight management and metabolic health more challenging.

Your PNPLA3 genotype can cause periods of weight regain to have a larger impact on your liver health than for most people.
‍
Over the last 12 months, your body weight cycled between 171 lbs and 192 lbs while your GGT (Gamma-Glutamyl Transferase), a marker of long-term liver stress, increased from 16 U/L to 34 U/L, and your fasting insulin increased from 7.2 to 10.9 μIU/mL. Unlike a single period of weight gain, repeated cycles of losing and regaining weight can place increasing stress on your liver, especially for individuals with your genotype. Maintaining a stable body composition appears to be more beneficial than repeatedly losing and regaining weight.

Your TCF7L2 genotype suggests you may be particularly sensitive to when carbohydrates are consumed.

Across multiple meals containing approximately 75g of carbohydrates, your blood sugar increased an average of 42 mg/dL when consumed after 8 PM compared to 26 mg/dL when consumed before 6 PM. Although your meal composition remained the same, these excessive blood sugar spikes can make weight management more challenging over time.

Your TCF7L2 genotype can make long-term blood sugar control more challenging than it is for most people.

During Q1, when your body weight decreased from 196 lbs to 180 lbs through a sustained caloric deficit and strength training 3 times a week, your Hemoglobin A1c, a marker of average blood sugar levels over the past 2–3 months, improved from 5.8% to 5.4%. During that same period, your average post-meal blood sugar levels declined by 18%. The reduction in body weight improved your body's sensitivity to insulin, allowing glucose to be cleared from the bloodstream more efficiently and improving long-term blood sugar control.

Your TCF7L2 genotype makes your body less efficient at clearing glucose from the bloodstream, increasing the amount of insulin you need following a meal.

Over the last 6-months, your strength training sessions increased from 2 to 4 sessions per week and your lean body mass increased by 8 lbs, which resulted in your fasting insulin decreasing from 14.2 to 8.9 μIU/mL - despite only a 6 lb reduction in body weight. The increase in muscle mass improved your body's ability to absorb and store glucose, reducing the amount of insulin needed to maintain healthy blood sugar levels.

Your APOE genotype can make your LDL cholesterol levels more sensitive to saturated fat intake than for most people.

In Q4, your saturated fat intake averaged 42 grams per day, and your LDL cholesterol increased from 112 mg/dL to 141 mg/dL. After reducing saturated fat intake to around 20 grams per day while maintaining a similar calorie intake, your LDL cholesterol decreased to 118 mg/dL. For individuals with your genotype, elevated LDL may contribute to cholesterol accumulating within artery walls over time which increases your long-term cardiovascular risk. Your data suggests that reducing saturated fat intake has a meaningful impact on lowering that risk without requiring weight loss or major dietary changes.

Your APOE genotype can make it more difficult for you to clear cholesterol-carrying particles from the bloodstream than for most people.

During Q2, your fiber intake increased from 14 grams to 32 grams per day and your Apolipoprotein B (ApoB), a measure of the number of cholesterol particles capable of entering artery walls, decreased from 112 mg/dL to 84 mg/dL. During that same period, your body weight remained within 2 lbs of your 168 lb average. This improvement in your ApoB was driven more by the additional fiber in your diet than by weight loss itself. Fewer circulating ApoB particles means fewer opportunities for cholesterol to accumulate within the arteries over time, and thus supports better long-term cardiovascular health.

Your APOE genotype influences how cholesterol is transported throughout the body, making Total Cholesterol an incomplete measure of your cardiovascular health on its own.

During the last 9-months  your Zone 2 exercise increased from 45 to 180 minutes per week on average, your Total Cholesterol remained relatively unchanged at 212 mg/dL. However, your HDL cholesterol increased from 48 to 67 mg/dL and your Cholesterol-to-HDL ratio improved from 4.4 to 3.2. HDL helps remove excess, dangerous cholesterol from your bloodstream and transport it back to your liver for recycling or removal. By increasing cardiovascular exercise, your body became more efficient at clearing cholesterol, improving one of the strongest indicators of long-term heart health despite a relatively minimal change in Total Cholesterol.

Your IL6 variant is associated with a stronger inflammatory response to physical and environmental stressors.

Over the last 4 months, each travel day was followed by an average of 3 consecutive nights with less than 6.5 hours of sleep. During that same time your hsCRP increased 63% from your previous test, meaning the combination of frequent travel and accumulated sleep debt may have amplified inflammation and reduced your ability to recover.

Your IL6 genotype is associated with greater immune activation when your recovery doesn't keep pace with your physical stress.

Over the last 12-weeks you averaged 5 strength-training session and just one full recovery day per week, compared with your usual 4 training days and 2 recovery days. During this time your White Blood Cell count increased by 18% despite no reported illness, while your Baseline Score remained unchanged. In previous periods when you averaged 2 recovery days per week your Baseline Score consistently improved by an average of 4 points. This suggests you exceeded the amount of training your body could effectively recover from, resulting in more immune activity without any additional athletic benefit.

Your IL6 genotype is associated with a more reactive immune response during periods of physiological stress.

Over the last 4-months your caloric intake increased by an average of 350 calories per day to support your new strength training load of 5 days a week. During this same time your Neutrophil count decreased 15% from your previous test, your Resilience improved by 12%, and your Baseline Score increased by 5 points. Increasing energy availability allowed your body to dedicate fewer resources to managing stress and more resources to improving performance.

Your FUT2 genotype influences the composition of your gut microbiome and how it responds to dietary change.

Over the last 6-months you increased your average fiber intake from 18g to 34g on average per day, and your hsCRP, a biomarker of inflammation, decreased by 44%. During that same period, your Resilience Score improved by 13% and the amount of days below your baseline were cut in half. The increase in fiber likely supported a healthier gut environment, which reduced inflammation and improved your ability to recover from daily stress.

Your FUT2 genotype influences the environment that supports your gut microbiome and how nutrients are processed within your digestive tract.

Over the last 12-months you increased your animal protein intake from 3 to 6 servings per week, and your Vitamin B12 increased by 41%. During that same period, your Resilience Score improved by 12% and days below your Resilience baseline decreased by 24%. Increasing the availability of B12 provided your body the nutrients needed to support energy production and recovery which contributed to improved day-to-day resilience.

Your FUT2 genotype makes the quality and diversity of your diet particularly important for shaping the health of your gut microbiome.

During the last 9-months you increased your intake from 8 to 17 different fruits and vegetables per week, and your Folate increased by 36% from your previous test. During that same period, your hs-CRP, a marker of inflammation, decreased from 2.5 to 2.0 mg/L and your average recovery time following high-Strain days decreased by 18 hours - despite maintaining a similar training load. The increase in dietary diversity likely supported a healthier gut environment, improving nutrient availability and reducing systemic inflammation, which allowed your body to recover more efficiently.

Your CRP-locus variant is associated with a stronger inflammatory response to physical and environmental stressors.

Since identifying this variant 2 years ago, you've increased your average sleep duration by 54 minutes per night. During that same period, hsCRP, a marker of inflammation, decreased by 42% from your 2025 baseline, and your Resilience Score also improved by 11%. By prioritizing sleep, you reduced the inflammatory burden on your body and improved your ability to recover from daily physical and mental stressors.

Your CRP-locus variant is associated with a stronger inflammatory response to prolonged physical stress.

Looking across the last 3 months, the largest declines in your recovery consistently followed cycling sessions longer than 46 miles. After these sessions your next-day Resilience averaged 15% lower and your resting heart rate averaged 4 bpm higher than your baseline. For you, long-duration endurance training appears to carry a higher inflammatory cost than other forms of exercise.

Your CRP-locus variant is associated with a stronger inflammatory response to illness and physical stress.

Over the last 2 years, you were sick 7 times, and everytime you returned to training within 3 days of reported symptom resolution. In the 4 cases where your resting heart rate was still elevated, even though no symptoms were present, your Resilience Score took an average of 13 days to return to baseline. In the 3 cases where resting heart rate had already normalized, your Resilience recovered in just 6 days. For you, resting heart rate is a reliable indicator of recovery readiness than symptoms alone.

Your MTHFR C677T genotype makes it harder for your body to keep your homocysteine in a healthy range.
‍
Homocysteine is a natural byproduct of protein metabolism that can accumulate when folate and vitamin B12 levels are too low. Over the last 6-months your leafy green vegetable intake increased from 2 to 7 servings per week and a methylated B-complex was added to your daily routine. This increased your folate increased from 7.1 to 13.4 ng/mL, your vitamin B12 increased from 420 to 780 pg/mL, and your homocysteine decreased from 14.2 to 10.1 µmol/L. Lowering homocysteine reduced a biomarker associated with long-term cardiovascular and cognitive risk, helping offset one of the biggest biological disadvantages associated with your genotype.

Your MTHFR C677T genotype means your body has less margin for error when folate levels begin to decline.

When your folate decreased from 13.1 to 7.4 ng/mL, your homocysteine increased 39%, which means your body is more sensitive to changes in nutrient consumption.  For you, maintaining adequate folate not only prevents deficiencies, but also maintains the nutrients your brain and cardiovascular system rely on to perform at their best.

Your MTHFR variant is associated with how strongly your cardiovascular fitness responds to endurance training.

Over the last 6 months, you increased endurance training from 2 to 4 sessions per week. During that same period, your Endurance Score went from 57 to 72 and your 1,000-meter row time improved by 16 seconds. Your largest gains in endurance have occurred during periods of consistent endurance training, suggesting this type of training may be particularly effective for improving your cardiovascular fitness.

Your BDNF variant means aerobic exercise may be one of the most influential drivers of adaptation in your biology.

Over the last 9-months your VO2 max increased from 39 to 47 while your Resilience improved by 21%. Unlike many people who view cardio purely as a fitness tool, your data suggests improvements in aerobic capacity are accompanied by broader improvements in your recovery and adaptability. For you, spending at least 18 minutes in Zone 3 in 3 of your 5 weekly training sessions will help  strengthen your ability to respond to future physical and cognitive stressors.

Your BDNF variant is associated with lower baseline production of the protein that maintains and repairs neural connections, and vitamin D is one of the signals that tells your cells to make more of it.

Between October and February your morning outdoor light exposure fell from 51 minutes on average to just 19, and you vitamin D levels decreased from 49 ng/mL to 21 ng/mL. For most people this is a routine seasonal dip, but with your BDNF genotype this dip in vitamin D may cause your focus to slip - which is most likely why your phone pickups increase by 19% over this time.

Your BDNF variant means aerobic work does double duty for you, increasing both glucose control and the neurotrophic signaling your brain uses to stay adaptable.

In the ten weeks following your ankle injury your Zone 2 minutes fell from a weekly average of 190 to just 40, and your daily step count dropped by 4,100. During this time your VO2 max declined 7.8 points, your morning readiness score fell 11%, and your HbA1c rose from 5.2% to 5.5%. As your aerobic activity declined, both your metabolic health and recovery capacity shifted negatively, and because your BDNF variant makes exercise an important driver of adaptation, the reduction in movement may have had a larger downstream impact than it would for the average person.

Your COMT variant influences how efficiently your brain recovers from stress.

From your birthday on May 1st through the first week of June you averaged less than 6 hours of sleep per night, and your Resilience Score declined from 84 to 66 while maintaining your 4 to 5 strength training sessions per week. After returning to an average of 7.5 hours of sleep per night over the last 3 weeks your Resilience recovered to 86. Your data suggests the decline in resilience was more closely tied to sleep than training volume, and while your workouts remained consistent, your recovery did not begin improving until your sleep duration increased.

Your COMT variant may make your response to stress more sensitive to changes in recovery behaviors such as sleep.

From the first of the year through February 15th your average work hours at the office increased from 42 to 58 , your sleep declined to less than 6 hours per night on average while training volume remained unchanged. During this period, your Resilience Score fell from 84 to 66 and your HRV trended lower by over 12 points. After your work hours returned closer to your baseline of 42, and your sleep increased to an average of 7.5 hours per night, your Resilience Score recovered over the following 3 weeks. Your workload and lack of sleep compounded over the course of 5 weeks which limited your recovery. Moving forward, if your work hours to increase it's important you prioritize getting at least 7.5 hours of sleep to support your nervous system and COMT variant.

Your COMT variant may make your nervous system more sensitive to prolonged periods of stress.

Over the last 10-weeks you had 14 travel days and 10 flights and your overnight HRV declined from 61 ms to 46 ms while your Resilience fell by 18%. The labs results from last week shows your hsCRP, an inflammation marker, increased from 0.8 to 2.1 mg/L despite no meaningful changes in training volume. Compare this to months where your travel schedule includes 2 or fewer flights your overnight HRV is above to recover within 72 hours of returning how and your resilience score only sees minimal fluctuations. Your data suggests the stress of travel lingers well beyond the travel itself, and a week of disrupted routines may require nearly three weeks of consistent recovery before your nervous system fully resets.

Your DIO1 rs2235544 variant is associated with less efficient conversion of T4 (thyroxine) into T3 (triiodothyronine), the active thyroid hormone that helps regulate metabolism and energy expenditure.

From February to April 2026, your Free T3 measured 2.8 pg/mL while you averaged approximately 1,600 calories, 6,500 steps per day, and 2 workouts per week. From May to July, after increasing your intake to approximately 2,100 calories per day, Free T3 increased by 64%, daily steps increased to 9,100, and you completed 11 consecutive weeks without missing a planned workout. Your data suggests that when energy intake increased, thyroid hormone availability, daily activity, and training consistency improved together - making adequate fueling particularly important for sustaining your activity over time.

Your DIO1 rs2235544 variant influences how efficiently your body converts T4 into active T3, making changes in T3 particularly important to watch during periods of dietary restriction.

Between August and October 2025, your carbohydrate intake averaged 85 grams per day, Free T3 measured 2.8 pg/mL, and weight loss slowed to just 2 lbs despite maintaining a calorie deficit. Six months later, your carbohydrate intake averaged 220 grams per day, Free T3 increased to 3.6 pg/mL, and your body weight decreased by 8.7 lbs over the same 3-month period. In your data, the higher-carbohydrate period coincided with both higher active thyroid hormone levels and faster weight loss, suggesting aggressive carbohydrate restriction may not support your best long-term fat-loss response.

Your DIO1 genotype influences how efficiently your body activates your thyroid hormones, which plays an important role in regulating your metabolism and glucose utilization.

Over the last 12-months your body weight increased by 18 lbs, your fasting glucose increased from 88 to 103 mg/dL, and your Free T3 (Triiodothyronine) declined from 3.4 to 2.8 pg/mL despite relatively stable Free T4 levels. Your data suggests the increase in blood sugar occurred alongside a decline in your thyroid hormone activation, reducing your body's ability to efficiently use energy. Changes in your T3 may provide an early signal that metabolic health is beginning to shift.

Not everyone benefits from higher testosterone in the same way, and your SHBG (Sex Hormone-Binding Globulin) genotype influences how much of your testosterone remains available for your muscles, brain, and other tissues.

Over the last 12-weeks, your Free Testosterone increased from 8.2 to 12.6 ng/dL, you added 4.8 lbs of lean mass and increased your squat strength by 18% despite Total Testosterone remaining relatively unchanged. Your data suggests the change wasn't how much testosterone your body produced, it was how much became available for your body to use. SHBG may be one of the clearest indicators that improvements in body composition are translating into better hormone function.

Your SHBG genotype makes your SHBG (Sex Hormone-Binding Globulin) levels highly responsive to changes in body composition and is closely linked to your metabolic health.

Over the last 12-weeks, your body weight decreased from 190 to 178 lbs and your SHBG increased from 19 to 31 nmol/L, moving into a healthier range. Higher SHBG levels are associated with better blood sugar control, a lower risk of developing type 2 diabetes, and healthier hormone regulation. As your weight decreased, SHBG increased by 63%, suggesting changes were occurring beneath the surface, ones your scale couldn't measure. For you, a decreased in SHBG is an early warning signal for potential weight gain and your metabolic health, especially when it’s paired with declining insulin results.

Your SHBG genotype makes SHBG (Sex Hormone-Binding Globulin) highly responsive to changes in body composition.

Over the last 5 years, your body weight increased by 28 lbs while your SHBG declined from 42 to 19 nmol/L. During that same period, fasting glucose increased gradually from 88 to 101 mg/dL and eventually entered the prediabetic range. While glucose changed by just 13 mg/dL over this period, your SHBG declined by more than 50%, making it one of the clearest indicators that your metabolism was moving in the wrong direction. Long before glucose became concerning, SHBG showed your weight gain was having a measurable impact on your metabolic health.

You carry a version of the FSHR gene that makes your reproductive hormones more irregular when you do not sleep enough.

Over the last 6-weeks, you averaged 5.2 hours of sleep per night and your estradiol measured 38 pg/mL. When compared to your Q2 2026 report your estradiol was roughly 60% higher, which is likely because you were averaging 7.1 hours of sleep per night. Aim to sleep 7 hours or more per night so your reproductive hormones remain stable.

You carry a version of the FSHR gene that makes it harder for you to remove excess estrogen from your body, and alcohol can amplify hormone fluctuations that negatively impact your health.

Over the last 6-weeks you averaged 3 drinks per week and your estradiol measured 34 pg/mL - while your body weight held steady. When compared to your Q2 2026 report that averaged 12 drinks per week, your estradiol was 55% higher, your free testosterone was 31% lower, and your body weight increased 7.4 lbs. Drinking more frequently pushes your estrogen up faster than it would for most men, and that combination shows up as weight gain that's harder to reverse.

You carry a version of FSHR that makes ovarian signaling take longer to recalibrate after stopping hormonal birth control.

Cycle-day-3 FSH drawn 6 weeks after stopping the pill measured 4.2 mIU/mL, with your cycles ranging from 21 to 40 days. Cycle-day-3 FSH drawn again at 16 weeks measured 7.6 mIU/mL, with cycles stabilized to a 28-day average. This recalibration window runs longer than it would for someone without this variant,  as irregular cycles in the first few months off birth control are simply a longer reset.

Your GSTM1 genotype gives you less antioxidant capacity to buffer the effects of prolonged stress.

Over the last 10 weeks, you averaged 31 hours of meetings per week and your overnight HRV fell from an average of 58 ms to 44 ms despite no meaningful change in sleep or training. Your most recent blood draw also showed an increase in hsCRP, a marker of systemic inflammation. During periods when your meeting load was below 20 hours per week, your HRV averaged 55 ms and hsCRP was 52% lower. In your data, whenever meeting load exceeded 27 hours per week, inflammation increased and recovery declined, suggesting prolonged work stress places a greater physiological burden on your body.

Your GSTM1 genotype gives you less antioxidant capacity to protect against oxidative stress.

Over the last 12 weeks, your alcohol intake averaged 8 drinks per week, your overnight HRV declined from 56 ms to 43 ms, and LDL increased from 108 to 142 mg/dL despite minimal change in body weight. During periods when your alcohol intake was fewer than 2 drinks per week, HRV averaged 22% higher and LDL was around 116 mg/dL. Your data suggests higher alcohol intake has a measurable impact on both your recovery and cardiovascular markers, making alcohol exposure particularly important for you to manage.

Your GSTM1 genotype gives you less antioxidant capacity to buffer the effects of prolonged physiological stress from travel.

Over the last 8 weeks you took more than 14 flights and at more than 30 meals out. During this period your overnight HRV declined from 61 ms to 45 ms despite maintaining a consistent workout routine, and your ALT increased from 19 to 41 U/L and AST from 18 to 34 U/L. The cumulative stress of travel, inconsistent routines, and reduced recovery is creating a burden your body is struggling to keep up with. Combined with your GSTM1 genotype, these periods of prolonged stress may be placing greater demands on your liver and recovery systems.

Your GSTP1 genotype may make you more sensitive to the inflammatory effects of prolonged oxidative stress.

Over the last 12-weeks you average 9 drinks per week and your overnight HRV declined from 57 ms to 43 ms. During this time your hsCRP, an inflammatory marker, also increased from 0.8 to 2.4 mg/L, despite no meaningful change in sleep, training, or body weight.. When your alcohol intake is fewer than 2 drinks per week your HRV sits at 55 ms and your hsCRP is on average 0.9 mg/L. When your alcohol intake exceeds approximately 7 drinks per week, inflammation increases and your recovery declined, suggesting your body is carrying more oxidative stress than it can effectively clear.

Your GSTP1 genotype may make you more sensitive to the effects of prolonged oxidative stress.

Over the last 10-weeks you averaged less than 6 hours of sleep per night, your overnight HRV declined from 59 ms to 44 ms and your GGT (a liver enzyme that helps recycle glutathione, the body's primary antioxidant) increased from 17 to 34 U/L. When GGT rises, it can be a sign that your body is working harder to manage oxidative stress. When sleep returned above 7 hours per night, HRV recovered and your GGT returned to baseline. When your sleep consistently falls below 6.5 hours per night, your liver begins to show measurable signs of stress despite no meaningful changes in alcohol intake, exercise, or body weight.

Your GSTP1 genotype may make you more sensitive to the effects of oxidative stress.

Over the last 10-weeks roughly 35% of your caloric intake was from ultra-processed foods. During this time your overnight HRV declined from 61 ms to 43 ms and your hsCRP, a systemic inflammatory marker, increased from 0.8 to 2.1 mg/L despite no meaningful changes in sleep duration, training volume, or body weight. When your processed food intake is below 15% of your daily calorie consumption, your HRV sits at 58 ms and your hsCRP maintains a healthy baseline. Whenever processed foods  exceeded one-third of your daily calories your inflammation increases and your recovery declines, suggesting your body is carrying more oxidative stress than it can effectively clear.

Your CYP1A2 genotype causes you to clear caffeine slower than average, making you more susceptible to the cumulative effects of an afternoon coffee.

During periods where you consumed caffeine after 2 PM for 3 consecutive days your Sleep Efficiency decreased by an average of 9% and the time you spent awake during the night increased by 24 minutes. After 5 consecutive days, your Sleep Efficiency decreased by 15% and your Resilience Score declined by 12%. When afternoon caffeine was avoided for at least 2 consecutive days, both metrics returned to your healthy baseline. The accumulation of multiple days of afternoon caffeine without giving your body enough time to fully clear the stimulant decreases how effectively you recover.

Your CYP1A2 genotype causes you to process caffeine slower than average.

On nights you consumed caffeine after 2 PM your overnight HRV decreased by 28% and your Resilience Score dropped by an average of 11% - even though your total sleep duration stayed roughly the same.
When compared to nights where no caffeine was consumed after noon your body had no adverse affects.

Your CYP1A2 variant allows you to clear caffeine more efficiently than average.
‍
Over the last 8-weeks you drank caffein prior to 91% of your strength sessions. During this time your Baseline Score increased by 12 points   and you completed an average of 5 out of 6 planned workouts each week. During the 6-weeks prior to this period, when no pre-workout caffein was consumed, your Baseline Score increased by just 3 points and your training consistency fell to 3 out of 6 planned workouts per week. Sleep Efficiency remained unchanged throughout both periods suggesting caffeine improves your training quality and consistency without hurting your recovery.